SCOTUS likely to reverse Helsinn v Teva ruling, say lawyers

04-12-2018

SCOTUS likely to reverse Helsinn v Teva ruling, say lawyers

phototechno / iStockphoto.com

The US Supreme Court will today hear a patent dispute between Helsinn Healthcare and Teva Pharmaceuticals, with lawyers telling WIPR that the probable reversal in the case will have a wide-ranging impact.


US Supreme Court, patentability, America Invents Act, Teva, Helsinn, on-sale bar, patent invalidation, Aloxi, palonosetron hydrochloride, statutory meaning

WIPR